Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Drug-induced liver injury (DILI) is often caused by innate and adaptive host immune responses. Characterization of inflammatory infiltrates in the liver may improve understanding of the underlying pathogenesis of DILI. This study aimed to enumerate and characterize leucocytes infiltrating liver tissue from subjects with acute DILI (n = 32) versus non-DILI causes of acute liver injury (n = 25). Immunostains for CD11b/CD4 (Kupffer and T helper cells), CD3/CD20 (T and B cells) and CD8/CD56 [T cytotoxic and natural killer (NK) cells] were evaluated in biopsies from subjects with acute DILI, either immunoallergic (IAD) or autoimmune (AID) and idiopathic autoimmune (AIH) and viral hepatitis (VH) and correlated with clinical and pathological features. All biopsies showed numerous CD8+ T cells and macrophages. DILI cases had significantly fewer B lymphocytes than AIH and VH and significantly fewer NK cells than VH. Prominent plasma cells were unusual in IAD (three of 10 cases), but were associated strongly with AIH (eight of nine) and also observed in most with AID (six of nine). They were also found in five of 10 cases with VH. Liver biopsies from subjects with DILI were characterized by low counts of mature B cells and NK cells in portal triads in contrast to VH. NK cells were found only in cases of VH, whereas AIH and VH both showed higher counts of B cells than DILI. Plasma cells were associated most strongly with AIH and less so with AID, but were uncommon in IAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies of infiltrating lymphocytes in the livers of patients with DILI have demonstrated unique cellular profiles, but further studies are needed to improve our understanding of the immunopathogenesis of DILI with the hope of preventing disease progression and identifying targets for therapeutic intervention.220”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct
Fontana, R. J., Watkins, P. B., Bonkovsky, H. L., Chalasani, N., Davern, T., Serrano, J., & Rochon, J. (2009) · Drug Safety · doi:10.2165/00002018-200932010-00005 · Cited by 486
Self-citationLiver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network
Navarro, V. J., Barnhart, H., Bonkovsky, H. L., Davern, T., Fontana, R. J., Grant, L., Reddy, R. K., Seeff, L. B., Serrano, J., Sherker, A. H., et al. (2014) · Hepatology · doi:10.1002/hep.27317 · Cited by 418
Self-citationMichael, S. L., Pumford, N. R., Mayeux, P. R., Niesman, M. R., & Hinson, J. A. (1999) · Hepatology · doi:10.1002/hep.510300104 · Cited by 335
Attenuated liver fibrosis in the absence of B cells
Novobrantseva, T. I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24798 · Cited by 277
Research works printed but not linked: 26
- Kelly, 1999, Acute liver failure, Indian J Pediatr, 66, S104
- Wasley, 2008, Surveillance for acute viral hepatitis – United States, 2006, MMWR Surveill Summ, 57, 1
- McFarlane, 2004, Autoimmunity and the female liver, Hepatol Res, 28, 171, 10.1016/j.hepres.2003.12.002 · DOI
- Washington, 2007, Autoimmune liver disease: overlap and outliers, Mod Pathol, 20, S15, 10.1038/modpathol.3800684 · DOI
- Bahjat, 2007, Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease, J Immunol, 179, 7376, 10.4049/jimmunol.179.11.7376 · DOI
- Doherty, 2000, Innate and adaptive lymphoid cells in the human liver, Immunol Rev, 174, 5, 10.1034/j.1600-0528.2002.017416.x · DOI · Paper page
- Jost, 2013, Control of human viral infections by natural killer cells, Annu Rev Immunol, 31, 163, 10.1146/annurev-immunol-032712-100001 · DOI · Paper page
- Kurachi, 2003, Kupffer cells modulate splenic interleukin-10 production in endotoxin-induced liver injury after partial hepatectomy, J Hepatol, 38, 193, 10.1016/S0168-8278(02)00354-9 · doi:10.1016/s0168-8278(02)00354-9
- Jaeschke, 2002, Mechanisms of hepatotoxicity, Toxicol Sci, 65, 166, 10.1093/toxsci/65.2.166 · DOI · Paper page
- Cheever, 1994, Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis, J Immunol, 153, 753, 10.4049/jimmunol.153.2.753 · DOI · Paper page
- Rockey, 2010, Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel–Uclaf causality assessment method, Hepatology, 51, 2117, 10.1002/hep.23577 · DOI · Paper page
- deLemos, 2014, Drug-induced liver injury with autoimmune features, Semin Liver Dis, 34, 194, 10.1055/s-0034-1375959 · DOI · Paper page
- Bonkovsky, 2012, Zakim and Boyer's hepatology – a textbook of liver disease, 417, 10.1016/B978-1-4377-0881-3.00025-5 · DOI
- Chalasani, 2008, Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States, Gastroenterology, 135, 1924, 10.1053/j.gastro.2008.09.011 · DOI · Paper page
- Ishak, 1995, Histological grading and staging of chronic hepatitis, J Hepatol, 22, 696, 10.1016/0168-8278(95)80226-6 · DOI · Paper page
- Kleiner, 2014, Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations, Hepatology, 59, 661, 10.1002/hep.26709 · DOI · Paper page
- Winwood, 1993, Kupffer cells: their activation and role in animal models of liver injury and human liver disease, Semin Liver Dis, 13, 50, 10.1055/s-2007-1007337 · DOI
- Kelly, 1998, Nitrofurantoin-induced hepatotoxicity mediated by CD8+ T cells, Am J Gastroenterol, 93, 819
- Kleiner, 2009, The pathology of drug-induced liver injury, Semin Liver Dis, 29, 364, 10.1055/s-0029-1240005 · DOI · Paper page
- Kaplowitz, 2004, Drug-induced liver injury, Clin Infect Dis, 38, S44, 10.1086/381446 · DOI · Paper page
- Vogel, 2002, Autoimmunity and viruses, Clin Liver Dis, 6, 739, 10.1016/S1089-3261(02)00024-7 · DOI
- Rubio, 2012, Detecting plasma cell precursors in autoimmune hepatitis, In Vivo, 26, 319
- Suzuki, 2011, The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury, Hepatology, 54, 931, 10.1002/hep.24481 · DOI · Paper page
- Holt, 2008, Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury, J Leukoc Biol, 84, 1410, 10.1189/jlb.0308173 · DOI · Paper page
- Chitturi, 2007, Drug-induced liver disease, 702
- Fontana, 2010, Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop, Hepatology, 52, 730, 10.1002/hep.23696 · DOI · Paper page
Cited by
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationDrug-induced liver injury: recent advances in diagnosis and risk assessment
Kullak-Ublick, G. A., Andrade, R. J., Merz, M., End, P., Benesic, A., Gerbes, A. L., & Aithal, G. P. (2017) · Gut · doi:10.1136/gutjnl-2016-313369 · Cited by 438
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
“Studies of infiltrating lymphocytes in the livers of patients with DILI have demonstrated unique cellular profiles, but further studies are needed to improve our understanding of the immunopathogenesis of DILI with the hope of preventing disease progression and identifying targets for therapeutic intervention.[220]”
BackgroundSelf-citationPathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
Fontana, R. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.032 · Cited by 313
Self-citationDrug‐induced liver injury: Advances in mechanistic understanding that will inform risk management
Mosedale, M., & Watkins, P. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.564 · Cited by 203
Self-citationImmune-mediated drug-induced liver injury: immunogenetics and experimental models
Gerussi, A., Natalini, A., Antonangeli, F., Mancuso, C., Agostinetto, E., Barisani, D., Di Rosa, F., Andrade, R., & Invernizzi, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094557 · Cited by 87
“Neutrophils are a major component of liver infiltrate in DILI, as demonstrated by immunohistochemistry studies on liver biopsies [24].”
BackgroundDrug-induced liver injury: Highlights from a review of the 2015 literature
Sarges, P., Steinberg, J. M., & Lewis, J. H. (2016) · Drug Safety · doi:10.1007/s40264-016-0427-8 · Cited by 74
Mechanisms of idiosyncratic drug-induced liver injury
Uetrecht, J. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2018.12.001 · Cited by 49
Hepatic Damage by Natural Remedies
Medina-Caliz, I., Gonzalez-Jimenez, A., Garcia-Cortes, M., Lucena, M. I., & Andrade, R. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1623518 · Cited by 40
Lammert, C., Zhu, C., Lian, Y., Raman, I., Eckert, G., Li, Q., & Chalasani, N. (2020) · Hepatology Communications · doi:10.1002/hep4.1582 · Cited by 38
Self-citationWhritenour, J., Ko, M., Zong, Q., Wang, J., Tartaro, K., Schneider, P., Olson, E., Van Volkenburg, M., Serrano, J., Hayashi, P., et al. (2017) · Journal of Immunotoxicology · doi:10.1080/1547691x.2016.1254305 · Cited by 37
Self-citation
Metadata
- Authors
- Foureau, D. M., Walling, T. L., Maddukuri, V, Anderson, W., Culbreath, K., Kleiner, D. E., Ahrens, W. A., Jacobs, C., Watkins, P. B., Fontana, R. J., Chalasani, N., Talwalkar, J., Lee, W. M., Stolz, A., Serrano, J., & Bonkovsky, H. L.
- Affiliations
- Departments of Medicine, Surgery, Pathology, the Liver-Biliary-Pancreatic Center, Immune Monitoring Core Laboratory, Dickson Center for Advanced Analytics, Carolinas HealthCare System, Charlotte, USA
- Laboratory of Pathology, NIH, Bethesda, MD, USA
- Hamner Institute of Health Sciences, University of North Carolina, Chapel Hill, NC, USA
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
- Department of Internal Medicine, IUPUI, Indianapolis, IN, USA
- Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
- Department of Internal Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA
- National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD, USA
- Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-03-10
- Volume
- 180
- Issue
- 1
- Pages
- 40-51
- ISSN
- 0009-9104
- 1365-2249
- Cited by
- 101
- References
- 4
- Language
- en
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- National Cancer Institute
- Acute Liver Failure Study Group (U01 DK-58369)
- Drug Induced Liver Injury Network (U01 DK-065193, U01 DK-065211, U01 DK-065238, U01 DK-065184, U01 DK-065201, U01 DK-83023, U01 DK-083020, U01 DK-08992, U01 DK-083027)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.